Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts [Yahoo! Finance]
Emergent BioSolutions Inc. (EBS)
Last emergent biosolutions inc. earnings: 4/30 04:08 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.emergentbiosolutions.com
Company Research
Source: Yahoo! Finance
COLUMBUS, Ohio, April 02, 2026 BUSINESS WIRE Clarametyx Biosciences, Inc . ("Clarametyx"), a clinical-stage biotechnology company developing immune-enabling therapies and vaccines to address biofilm-driven chronic respiratory disease, today announced two senior leadership positions within its executive team to support operational scale as the company advances its promising pipeline. Veronica Hall, PhD, has been promoted to Chief Development Officer and Head of R&D and Brendan Doran, PharmD, has been promoted to Chief Operating Officer. "As we rapidly move toward later stages of clinical development, these promotions sharpen our execution and strategic focus. Veronica will lead the strategic advancement of our development pipeline, bringing her deep scientific expertise and cross-functional leadership to drive our programs from research through clinical execution, while Brendan will leverage his operational expertise to scale our clinical infrastructure as we grow," said David V. Ri
Show less
Read more
Impact Snapshot
Event Time:
EBS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EBS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EBS alerts
High impacting Emergent BioSolutions Inc. news events
Weekly update
A roundup of the hottest topics
EBS
News
- Emergent BioSolutions Participates in Upcoming International Preparedness ConferencesGlobeNewswire
- How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story [Yahoo! Finance]Yahoo! Finance
- Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical CountermeasuresGlobeNewswire
- How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset [Yahoo! Finance]Yahoo! Finance
- BioThrax (Emergent BioSolutions) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]Yahoo! Finance
EBS
Earnings
- 10/29/25 - Beat
EBS
Sec Filings
- 4/1/26 - Form 144
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form ARS
- EBS's page on the SEC website